Read More Pharma Industry News Did Tango Therapeutics Inc. just turn one cancer data shock into a $600m runway? Find out how Tango Therapeutics Inc.'s $600 million offering could reshape TNGX sentiment, dilution risk, and its oncology runway. byPallavi MadhirajuJune 10, 2026